Cardiac Ablation Market Analysis

Cardiac Ablation Market Analysis

Based on product, the cardiac ablation market is divided into cryoablation devices, ultrasound ablators, electrical ablators, radiofrequency (RF) ablators, and others. The electrical ablators segment is anticipated to record a 14% CAGR from 2023 to 2032. Increasing R&D efforts for bringing advanced therapeutic procedures to treat chronic cardiac disorders is anticipated to expand product development. Moreover, the consistent development of surgical technologies for replacing traditional treatments is likely to spur segment expansion.
 

cardiac ablation market from open/surgical approach segment held over USD 960 million in 2022. These procedures are used for the treatment of atrial fibrillation and other CVDs. As per the Heart and Stroke Foundation, approximately 25% of all stroke cases after 40 years are due to atrial fibrillation which depicts its high occurrence. Rising prevalence of atrial fibrillation should boost the uptake of open/surgical procedures, which is likely to propel segment outlook.
 

Cardiac ablation market share from the tachycardia segment is expected to record over 14.5% CAGR from 2023 to 2032. The increasing number of patients suffering from tachycardia has risen considerably over recent years. Strenuous exercise or stress are some of the factors that can led to unusual rise in heart rate. As per CDC, tachycardia affects nearly 1 in every 300 people in the U.S. The condition is mainly occurring amongst the elderly and female population.
 

With respect to end-use, the industry is segmented into ambulatory surgical centers, cardiac centers, hospitals, and others. Amongst them, the cardiac centers segment is likely to hold over 20% market share by 2032. These centers are increasingly deployed across developing economies as it offers advanced treatment alternatives. The need for more effective treatment solutions should increase patient footfall across these centers. Moreover, cardiac centers also offer preliminary care and adequate treatment to patients undergoing cardiac ablation procedures, which may complement segment growth.
 

Europe cardiac ablation market is poised to reach over USD 4 billion by 2032. Rising adoption of innovative technologies in the health care sector coupled with increasing per capita income in the region is expected to support this share. The demand for cardiac ablation devices can also increase in the region given to the presence of the elderly population that is highly susceptible to various chronic diseases.